The N-myc gene is a member of the myc gene family (1) and encodes a nuclear protein (12, 26, 30) . Expression of N-myc is very high in the early embryonic period and declines dramatically during later development, except in a few specific tissues (13, 34) . This is in contrast to the expression of c-myc which is less dependent on the developmental stage (13, 34) . Recent analysis of organogenesis in the developing mouse (23) indicated that N-myc expression takes place specifically in an early phase of terminal differentiation of the cells. These results on the spatiotemporal specificity of N-myc expression suggest that the N-myc gene plays an important role in the developmental process. However, there is as yet no experimental evidence to support this hypothesis.
One approach to the analysis of N-myc function in early embryos is to use teratocarcinoma stem cells as a model, since they have many properties common to early embryonic cells and their differentiation state can be easily manipulated in vitro. Indeed, it has been shown that N-myc mRNA is expressed at a high level in teratocarcinoma stem cells (13, 28) .
We analyzed N-myc expression in teratocarcinoma stem cells and their differentiated derivatives, particularly during endodermal differentiation induced by retinoic acid (RA) or RA plus dibutyryl cyclic AMP (db-cAMP). We found that a steep yet transient decrease of N-myc mRNA and protein accompanied the differentiation. Comparison of the time course of this response with that of other markers indicated that it is one of the earliest events in the process of RA-induced differentiation. We also examined whether the decrease of N-myc expression is the cause or the result of t Present address: Department of Embryology, Carnegie Institution of Washington, Baltimore, MD 21210. differentiation by introducing a gene construct which expresses N-myc constitutively.
MATERIALS AND METHODS Cell culture. The mouse cell lines used were teratocarcinoma stem OTF9 ( a derivative of F9 [27] ) and PCC3/A/1 (11) , parietal yolk sac PYS (19), neuroblastoma NB2A (16) , and fibroblast STO (20) . All were maintained in Dulbecco modified Eagle medium containing 10% fetal calf serum. To induce differentiation of OTF9, we added 200 nM RA or 200 nM RA plus 1 mM db-cAMP to the culture medium (9) .
Blotting analysis. Cytoplasmic RNA was isolated from the cells by phenol extraction and analyzed by Northern (RNA) blotting (9) . Probes used were the 2.4-kilobase (kb) BamHIEcoRI fragment of mouse N-myc cDNA clone (see below), the 400-base-pair (bp) BamHI-XhoI fragment of mouse cmyc cDNA exon 1 (2), the 500-bp Hoxl.1 cDNA (provided by N. Takahashi), the 3.1-kb laminin B1 cDNA (21) , and the 2.0-kb chicken ,-actin cDNA clone pAl (4) .
A synthetic 14-amino-acid peptide (SPYVESEDAPPQ KK, derived from the mouse N-myc sequence) was coupled to keyhole limpet hemocyanin (Calbiochem-Behring) with glutaraldehyde, and antiserum was raised in a rabbit. To obtain nuclear protein extract, we disrupted cells in 10 mM Tris hydrochloride (pH 7.5)-10 mM NaCl-3 mM MgCl2-0.5% Triton X-100 in a Dounce homogenizer. Nuclei (5 x 107) were collected, suspended in 500 ,ul of 2% sodium dodecyl sulfate-62.5 mM Tris hydrochloride (pH 6.8), sonicated for 30 Isolation and expression of N-myc cDNA in OTF9. A XgtlO clone carrying a 2.5-kb N-myc cDNA was isolated from a cDNA library of PSA5-E (24), and the insert was recloned into the EcoRI site of pIBI76 (International Biotechnologies, Inc.) to give clone pNc-1. The cDNA sequence started 40 bp downstream of transcription initiation sites (14) and ended 4 bp downstream of the poly(A) addition signal, AATAAA. This cDNA was placed under the control of the Rous sarcoma virus long terminal repeat and the chicken 13-actin promoter to give pmiwNmyc ( Fig. 1 ) by following the steps described below.
PstI fragments upstream of the chicken P-actin promoter in ppactCAT9 (8) were replaced with a Rous sarcoma virus long terminal repeat sequence (530-bp PstI-BstNI fragment of pSR1 [33] ), after blunting the DNA ends, to give pmiwCAT. pmiwCAT was then cleaved at the HindIII and HpaI sites to remove the chloramphenicol acetyltransferase (CAT) coding sequence. The 2.4-kb BamHI fragment of clone pNc-1 was recloned in the BamHI site of pUC19 with the 5' end near the HindIII site. The 1.6-kb HindIII-DraI fragment, containing the entire coding sequence, was reexcised and inserted in the HindIII-HpaI sites of CAT-deleted pmiwCAT. The plasmid was finally digested at the HindIll and Sall sites located immediately adjacent to the 5' end of the N-myc cDNA sequence, made blunt at the ends, and recircularized to create pmiwNmyc (Fig. 1) . The last procedure removed an unnecessary ATG codon in the pUCderived sequence present as a part of the SphI site.
To obtain transformants with plasmid pmiwNmyc, ca. search Resources, Bank-Gene, deposit VE039) at 400 V for 1 ms in the GenePulser (Bio-Rad Laboratories). After 24 h in nonselective medium, G418 was added at 500 jxg/ml. RESULTS N-myc expression is very high in teratocarcinoma stem cells. It has been reported that some mouse teratocarcinoma stem cell lines express N-myc mRNA at a high level (13, 28) . We compared the mRNA level in the stem cell lines OTF9 and PCC3/A/1 with that in various mouse cell lines and developing embryos. The two stem cell lines expressed N-myc very abundantly, whereas the level in other cell lines was very low or undetectable (Fig. 2) . For comparison, the same blot was rehybridized with c-myc probe. Interestingly, the teratocarcinoma stem cell lines had a lower-level c-myc expression than other cell lines did. In the mouse embryo from 9.5 to 17.5 days, the expression of N-myc was highest at 9.5 days and decreased as development proceeded; the level of N-myc expression in teratocarcinoma stem cell lines was as high as in the 9.5-day embryo (data not shown).
Transient decrease of N-myc expression during endodermal differentiation of OTF9 cells. We analyzed N-myc expression during differentiation of the teratocarcinoma stem cell line OTF9 (Fig. 3) . The OTF9 stem cells were induced to differentiate either into primitive endoderm by the addition of RA or into parietal endoderm by the addition of RA plus RA RA+dbcAMP N-myc * Act s 'u. db-cAMP (9) . Previous studies of F9 and other teratocarcinoma stem cells have shown that N-myc expression decreases when they are subjected to long-term induction for differentiation by RA plus db-cAMP (13, 28) . The same decrease was observed in OTF9 cells after 5 days of induction (to roughly one-third of the level before induction) (Fig.  3) . Moreover, we found that a transient decrease in N-myc expression took place much earlier. The level of N-myc mRNA decreased dramatically after 1 day of induction (to 1/40 of the level before induction) and returned to the original level after 3 days. The time course was the same regardless of whether primitive or parietal endoderm was produced.
A more detailed time course of the change of the N-myc mRNA level was examined for the cells induced to differentiate into parietal endoderm (Fig. 4A) . A decrease in N-myc mRNA was already noticeable 3 h after addition of RA plus db-cAMP. The level of N-myc mRNA continued to decrease, reaching its minimum level after 24 h at about 1/40 of the level of the stem cells. The level of N-myc mRNA increased again after 30 h and returned to the original level after 72 h.
It has been reported that various genes change their mRNA levels when teratocarcinoma stem cells differentiate upon induction by RA or RA plus dbcAMP (see, for example, reference 29). In most cases, such changes begin relatively late, but there are a few cases when changes of mRNA levels occur much earlier after induction, e.g., the c-myc gene (6, 10) and some of the homeo-box-containing genes (3, 18) . To compare the expression of c-myc and Hoxl.1 genes with that of the N-myc gene, we performed Northern blot analysis with RNA extracted at various times after induction by RA plus db-cAMP (Fig. 5A) . The level of c-myc mRNA also decreased after 3 h of induction, increased slightly after 6 h, and decreased gradually thereafter. The overall decrease of c-myc mRNA was slower than that of N-myc mRNA, and the lowest level of c-myc was attained more slowly than that of N-myc. Hoxl.1 mRNA was not detectable in the undifferentiated state, became detectable 12 h after induction, reached its maximum level at about 48 h, and decreased thereafter. The same result was obtained by induction with RA alone. Thus, the decrease of N-myc gene expression is one of the very early responses of OTF9 cells to induction with RA or RA plus db-cAMP.
Constitutive expression of N-myc cDNA in OTF9 celis. One way to examine the causal relationship of the decrease of N-myc expression with differentiation of OTF9 cells is to investigate the effect of constitutive expression of N-myc protein on differentiation. If a decrease of N-myc expression is one of the requirements of differentiation, constitutive expression will block differentiation, as has been demonstrated for the c-myc decrease during differentiation of erythroleukemic cells (5, 7, 25) .
To attain constitutive N-myc expression, we placed the coding region of a mouse N-myc cDNA downstream of a strong, nonspecific enhancer-promoter complex of the Rous sarcoma virus long terminal repeat and the chicken ,-actin promoter, which we call the miw complex, to make the plasmid pmiwNmyc (Fig. 1) . We confirmed by using a transformation assay with rat embryo fibroblasts (REF) (32) that pmiwNmyc expressed functional N-myc protein. Trans The plasmid pmiwNmyc was introduced into OTF9 cell by coelectroporation with the drug-resistant gene pSTneoB ( Fig. 1) (15) , followed by selection with G418. A total of 32 resistant colonies were picked, and cytoplasmic RNA was examined by Northern blotting. Endogenous and exogenous transcripts were distinguished by their size difference (2.6 versus 1.6 kb). Four of the clones expressed exogenous N-myc gene very abundantly. Cytoplasmic N-myc RNA and nuclear N-myc proteins of those clones were examined after addition of RA or RA plus db-cAMP. As shown for the representative clone N1, the exogenous gene efficiently expressed a 1.6-kb transcript even after the addition of RA plus db-cAMP, although a slight decrease in expression was observed after 48 h (Fig. 4B) . The time course of the change of endogenous N-myc transcript was exactly the same as that for the parental OTF9 cell line (Fig. 4) . On Western blots the N-myc protein with apparent molecular weights of 62,000, 63,000, and 64,000 was observed in undifferentiated OTF9 cells, whereas no N-myc protein was detectable in the same OTF9 cells treated with RA plus db-cAMP (Fig. 6) . Thus, the change in the amount of N-myc protein paralleled that of N-myc mRNA. In contrast, clone N1 in its undifferentiated condition expressed severalfold more N-myc pro- with cytoplasmic RNA indicated that the expression of other genes, such as laminin B1 (a late differentiation marker of parietal endoderm [21] ), c-myc, and Hoxl.1, was also indistinguishable between OTF9 and the pmiwNmyc transformants (Fig. 5) . Therefore, it was concluded that constitutive N-myc expression did not affect the differentiation of OTF9 cells.
DISCUSSION
Changes of gene expression during endodermal differentiation of teratocarcinoma stem cells. Previous studies of F9 and other teratocarcinoma stem cells showed that the N-myc mRNA level decreases significantly after long-term induction with RA plus db-cAMP (13, 28) . Our present results revealed that a steep and transient reduction takes place in the earlier phase of the differentiation process (Fig. 3) . When OTF9 stem cells were induced to differentiate into primary or parietal endoderm, the N-myc mRNA level began to decrease within 3 h of induction, reached its minimum at 24 h, and returned to the original level after 72 h (Fig. 4A) . Western blot analysis with an N-myc-specific serum demonstrated that the decrease of N-myc protein paralleled that of N-myc mRNA (Fig. 6) .
It has been shown that c-myc and Hoxi .1 also change their expression levels shortly after induction of teratocarcinoma stem cells with RA (3, 6, 10) . Our results with OTF9 indicated that in contrast to the biphasic decrease of c-myc mRNA, the decrease of N-myc mRNA is much steeper and monophasic and the lowest level of N-myc mRNA is attained faster than that of c-myc mRNA ( Fig. 4A and 5A ). It also became clear that the decrease of N-myc mRNA levels takes place earlier than the increase of Hoxl.1 mRNA levels (Fig.  5A ). Constitutive N-myc expression does not affect differentiation of OTF9. To examine whether N-myc down-regulation is the cause of differentiation of OTF9 cells, we introduced into the cells the plasmid pmiwNmyc, which expressed N-myc cDNA constitutively, and observed a persistent and highlevel N-myc expression in the pmiwNmyc-transformed cells during the period following treatment with RA or RA plus db-cAMP in which endogenous N-myc expression was almost extinct (Fig. 4 and 6) .
All four clones of OTF9 which constitutively expressed pmiwNmyc-encoded N-myc protein differentiated into primitive or parietal endoderm indistinguishably from parental OTF9 cells. We used multiple criteria to assess differentiation: cell morphology and expression of early-and lateresponding genes such as c-myc, Hoxl.1, and laminin B1 (Fig. 5) . These results indicated that the decrease of N-myc expression cannot be the only cause of differentiation of OTF9 cells. Although the response of N-myc is initiated at a very early stage, its down-regulation may be one of the consequences of the earliest unknown reaction to the differentiation signal elicited by RA treatment. Alternatively, it is possible that N-myc down-regulation is in one of the key steps in RA-induced differentiation, but that the step is governed by several, redundant events which can lead to the next step of differentiation. In this case, the effect of maintaining a high N-myc level may have been bypassed through an alternative event.
Analogous cases in which putative regulatory genes change their expression in response to differentiation signals. There are a number of reported cases in which genes, especially those encoding nuclear proteins, change their expression level in response to differentiation signals. Because of the early response and putative regulatory functions, these changes are considered to play a key role in the differentiation process. However, there are only a limited number of cases demonstrating that such changes are in fact required for differentiation.
In mouse erythroleukemia cells, there are two phases of decrease in c-myc mRNA after induction for differentiation by dimethyl sulfoxide. Constitutive expression of exogenous c-myc during these phases efficiently blocked the differentiation (5, 7, 25) , thereby indicating that a decrease of c-myc expression is a prerequisite for the erythroid differentiation. On the other hand, c-fos expression occurs rapidly and transiently when monomyelocytic leukemia cells are induced to differentiate into macrophages, but it has been shown to be neither sufficient nor obligatory for differentiation (22) . In N-myc down-regulation in OTF9 differentiation reported here, constitutive N-myc expression did not affect differentiation. N-myc expression also decreases during neuroblastoma differentiation before morphological changes take place (31) . The same strategy as described here should be applicable to this and analogous phenomena.
